Editorial Series
Search for
Go
Sort by 
Page
Showing 1 - 12 of 12 documents.
Editorial series
Life and times of leading cardiologists with Rob Califf. Guest: Bob Harrington
Nov 6, 2009 09:50 EST
Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.
Editorial series
Clinical research: Comparing regulatory pathways in US and UK
Oct 30, 2009 12:35 EDT
How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.
Editorial series
Life and times of leading cardiologists with Rob Califf. Guest: Peter Sleight
2 COMMENTS - Oct 13, 2009 10:15 EDT
With the ISIS-1 trial, Dr Peter Sleight and his team at Oxford changed the approach to cardiovascular research. Join Dr Robert Califf as he talks to Dr Sleight about his journey from London to San Francisco to Oxford and finally to Italy, where he discovered the music of the heart.
Editorial series
ACC and AHA: Leadership in today's healthcare environment
Sep 15, 2009 14:10 EDT
Dr Robert Califf sits down with Drs Alfred Bove, Jack Lewin, and Clyde Yancy and AHA CEO Nancy Brown to talk about the ACC and the AHA and their role in the debate on healthcare reform.
The Cardiology Show
Best of Barcelona: PLATO and RE-LY
Sep 2, 2009 11:15 EDT
Dr Valentin Fuster returns to the city where he was born for a scintillating discussion with Drs Fox, Gershlick, Marrouche, Messerli, Spaulding, Vergheugt, Virmani, and Yancy about the miracle of RE-LY and the striking success of ticagrelor in the PLATO study.
Editorial series
After TIPS: What's next for the polypill?
1 COMMENT - Jun 15, 2009 09:30 EDT
Join Drs Salim Yusuf and Sanjay Kaul for an in-depth discussion on the promise and prospects of the polypill moderated by heartwire's Lisa Nainggolan.
Editorial series
Hypertrophic cardiomyopathy, athletes, and screening
Jun 5, 2009 09:30 EDT
Is it possible and desirable to envisage a nationwide system to screen athletes for hypertrophic cardiomyopathy? Drs Ommen, Maron, and Thompson examine the Italian screening data and review the implications of this model for the US.
Editorial series
Life and times of leading cardiologists with Rob Califf. Guest: Steve Nissen
1 COMMENT - Jun 1, 2009 10:20 EDT
Join Dr Robert Califf for a probing and personal interview with Dr Steve Nissen, about his activist days at the University of Michigan and the development of IVUS, to how he ended up at the Cleveland Clinic and what he thinks about the future of medicine in America.
The Cardiology Show
ACC 2009: From the eye of the storm in Orlando
Apr 2, 2009 15:35 EDT
Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.
Editorial series
Lipid lowering: The end or the means?
4 COMMENTS - Dec 9, 2008 16:46 EST
Dr Blumenthal talks to Drs Krumholz, Ridker, and Smith about how to approach target guidelines for LDL in the wake of JUPITER, SEARCH, and other lipid-lowering studies.
Ten years in review
Reviewing 10 years of cardiology news
1 COMMENT - Dec 3, 2008 14:30 EST
As theheart.org enters its 10th year join editor-in-chief, Dr Eric Topol, and his guests for a second look at the top news from the past decade. Throughout the coming months, we'll revisit the most important story from each of the last 10 years and ask: How has practice been affected? With time and perspective, what has changed and what have we learned?
The Cardiology Show
AHA 2008: The AHA Flies to JUPITER
3 COMMENTS - Nov 14, 2008 12:00 EST
Join Drs Krumholz, Blumenthal, Harrington, Jessup, Ridker, Smith, Stone, Weintraub, and Yancy as they dissect the results of the JUPITER and debate the far-reaching clinical implications of this landmark study in Part 1 of the program. In Part 2, the panelists look at the positive sides of HF-Action and TIMACS and deliberate the real lessons learned from these negative trials.

Search for
Go
Sort by 
Page
Showing 1 - 12 of 12 documents.
button
Previews
Featured programs
Poll
Would you prescribe BP-lowering medications to prehypertensive CAD patients with low levels of LDL cholesterol?
See: Very low LDL and normal BP result in slowest progression of atherosclerosis.
No
Yes

Vote
Inside: Prevention
More
More
Medscape
Assessing Risk and Enhancing Response in Patients With Coronary Artery Disease: The Role of Genetics
Sep 18, 2009 16:16 EDT
The following test-and-teach case is an educational activity modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and will then read evidence-based information that supports the most appropriate answer choice. Please note that these questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the case, there will be a short post-test assessment based on material covered in the activity.
Prevention
Assessing the Risk for Development of Heart Disease -- The Role of Genetics: An Expert Interview With John P. Kane, MS, MD, PhD
Sep 11, 2009 17:48 EDT
Genetic findings that affect the course of diseases have been increasing geometrically. Cardiology is one of the specialties that has benefited from recent discoveries. David Danar, MD, Scientific Director, MedscapeCME, interviewed John P. Kane, MS, MD, PhD, about the role of genetics in determining the risk for and management of heart disease.